AbCellera Biologics (ABCL) Net Income Growth (1y) (2021 - 2026)
AbCellera Biologics (ABCL) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-43.69% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
-73.01% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
AbCellera Biologics |
1.55 Bn |
1.44 Bn |
- |
5.38% |
| Date | Value |
|---|
| Mar 31, 2026 |
5.38% |
| Dec 31, 2025 |
73.85% |
| Sep 30, 2025 |
-11.76% |
| Jun 30, 2025 |
5.97% |
| Mar 31, 2025 |
-12.34% |
| Dec 31, 2024 |
27.44% |
| Sep 30, 2024 |
-78.63% |
| Jun 30, 2024 |
-20.97% |
| Mar 31, 2024 |
-1.25% |
| Dec 31, 2023 |
-57.73% |
| Sep 30, 2023 |
-207.46% |
| Jun 30, 2023 |
-349.93% |
| Mar 31, 2023 |
-123.79% |
| Dec 31, 2022 |
-149.86% |
| Sep 30, 2022 |
224.53% |
| Jun 30, 2022 |
-192.08% |
| Mar 31, 2022 |
43.81% |
| Dec 31, 2021 |
937.15% |
| Sep 30, 2021 |
-693.91% |
| Jun 30, 2021 |
-134.66% |
